Navigation Links
Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn
Date:2/1/2008

LA JOLLA, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) has announced that Douglas A. McClain, Jr., will resume the duties of CFO effective February 1, 2008. Mr. McClain also serves as the Company's Chairman of the Board and Corporate Secretary.

At the same time Immunosyn announced the resignation of G. David Criner as the company's Chief Financial and Accounting Officer. Mr. Criner, hired in October 2007, is leaving due to family matters.

"We appreciated David's expertise through this first leg of our development and welcome Douglas A. McClain, Jr. back in his former role as CFO. In the interim we have initiated a candidate search for a permanent CFO," commented Stephen D. Ferrone, CEO and President of Immunosyn Corporation.

About Immunosyn Corporation

La Jolla, CA-headquartered Immunosyn Corporation (OTC Bulletin Board: IMYN) plans to market and distribute life enhancing therapeutics. Currently, the company has exclusive worldwide rights from its largest shareholder, Argyll Biotechnologies, LLC, to market, sell and distribute SF-1019, a compound that was developed from extensive research into Biological Response Modifiers (BRMs). Argyll Biotechnologies, LLC has initiated the process for regulatory approval of SF-1019 in several countries and preparations for clinical trials are underway in both the US and Europe. Research suggests that SF-1019 has the potential to affect a number of clinical conditions including auto-immune disorders such as Multiple Sclerosis (MS), neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS) and complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and Diabetic Ulcers (DU).

Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securit
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
2. American Cancer Society to Present Highest Honor to Matthew L. Myers, Douglas R. Lowy, and Mark Schiffman for Outstanding Contributions to Cancer Fight
3. Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin
4. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
5. Immunosyn Corporation Names Stephen Ferrone as CEO
6. Immunosyn Corporation to Begin Trading
7. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
8. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...AJoseph Balboni loves sports. An avid tennis playe...-old insurance agent became increasingly frustrate...nus, a degenerative eye disorder. Unable to return..., he faced the prospect of a corneal transplant to...e years ago, Balboni discovered an alternative tre...
(Date:12/2/2009)...009 is the official congress of the European Assoc...nch of the European Society of Cardiology, where t...be presented. , New case reports will be presen...nce highlighting the role of this new technology. ...echniques, it is likely that non-invasive imaging ...
(Date:12/2/2009)... National Pen ( www.pens.com ), a wor...unced today it is giving away 10,000 free business...ember 2, 2009 -- National Pen ( www.pens.com ), a ...nounced today it is giving away 10,000 free busine...o promote business that no other company in the in...
(Date:12/2/2009)... Revolutionary new cell phones that d...rs will be available in early 2010 from Aerius Int...) December 2, 2009 -- Revolutionary new cell phone...from users will be available in early 2010 from Ae...y honored with a Green Technology Award in wireles...
(Date:12/2/2009)... On Sunday, more than 900 runners and...l cross the finish line at the Rock ‘n&rsquo...om, raising over $3.2 million for the Crohn,s &...ining program, Team Challenge (www.ccteamchallenge...will go toward research, education, and support in...
Breaking Medicine News(10 mins):Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:Media alert: EUROECHO 2009 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4
...sity researchers seem to know what makes certain b... Colleagues from Edinburgh University and th... closed in on the possible risk factors in prematu...s division, are team leaders of a research group t...
...ned itself many accolades for promoting good healt...t taste in diabetics' mouth. Researchers f...at applying honey on diabetic ulcers could heal th...ique therapy to about 6 diabetic patients. The the...
...sive therapy (ECT) helps patients with severe depr...should be considered more often in the earlier sta...e Southern Medical Journal. "Electroconvul... schizophrenia," writes Dr. Stephen Taylor of the ...
...ve reported the creation of the cells that help bu...have been derived from human embryonic stem cells... These cells have shown promise in lab animal...of these precursor cells, known as "hemangioblast...
...of government allopathic doctors in the country ar...imary Health Centres (PHCs) in position in rural a...rs of beds available in the rural government hospi...% of CHCs are located in government buildings. As ...
... Democratic Front (LDF) government, set to mark it...hat it is to blame for the deaths of 38 newborns i...acted infection in the labour room of the Sree Avi...e not amounting to murder over the deaths. A speci...
Other Medicine News:Health News:Despite Being Effective Electroconvulsive Therapy is Underused for Severe Depression 2
(Date:12/2/2009)..., Mich., Dec. 2 ALERT ALARM, a Mic...day announced the exclusive availability of new cr... to look like a piece of jewelry, these personal e...; immediate emergency medical response assistance....h/20091202/DE19790 ) ,, For elderly users, tho...
(Date:12/2/2009)...N, Fla., Dec. 2 America...(the Company), announces that the Disintegrator Pl...destruction device (NDD), is in its first producti...ll the current demand for home injection prescript...ecent passing of the SB 486 which requires Calif...
(Date:12/2/2009)..., Dec. 2 Cardinal Health... company,s board of directors, effective immediate...ve vice president and president of global pharmace... tenure with the company at the close of its merge...at Schering-Plough, Cox served as president of Pha...
Breaking Medicine Technology:World's Only FDA Approved Home Needle Destruction Device is in Production 2World's Only FDA Approved Home Needle Destruction Device is in Production 3Cardinal Health Names Carrie Cox to Board of Directors 2Sharing Prescription Meds Common Among U S Teens 54042 1Sharing Prescription Meds Common Among U S Teens 54042 2NCCN Stresses Importance of PSA Testing in High Risk Men 54037 1NCCN Stresses Importance of PSA Testing in High Risk Men 54037 2NCCN Stresses Importance of PSA Testing in High Risk Men 54037 3NCCN Stresses Importance of PSA Testing in High Risk Men 54037 4NCCN Stresses Importance of PSA Testing in High Risk Men 54037 5PTC Therapeutics Announces Achievement of Major Milestone in Schering Plough Hepatitis C Collaboration 13470 1PTC Therapeutics Announces Achievement of Major Milestone in Schering Plough Hepatitis C Collaboration 13470 2PTC Therapeutics Announces Achievement of Major Milestone in Schering Plough Hepatitis C Collaboration 13470 3
CLEARBLUE EASY OVULATION TEST
Achieva CV
ResMed AutoSet Spirit
BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre Attached Holder
Medicine Products: